Daniel L Moss

7PUBLICATIONS
23CO-AUTHORS
Medical infection agents (incl. prions)Micro- and nanosystemsAnimal protection (incl. pests and pathogens)Nutritional epidemiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 03, 2026
Neutralizing antibodies elicited in nonhuman primates by an enterovirus D68 virus-like particle vaccine target receptor binding sites.

|Dec 09, 2024
pH-Responsive Peptide Nanoparticles Deliver Macromolecules to Cells via Endosomal Membrane Nanoporation.

Eric Wu, Ace Ellis, Keynon Bell

|Apr 25, 2024
Enterovirus virus-like-particle and inactivated poliovirus vaccines do not elicit substantive cross-reactive antibody responses.

Daniel L Moss, Alden C Paine, Peter W Krug

|May 17, 2023
EV-D68 virus-like particle vaccines elicit cross-clade neutralizing antibodies that inhibit infection and block dissemination.

Peter W Krug, Lingshu Wang, Wei Shi

|Jul 14, 2022
CD4+ T-Cell Epitope Prediction by Combined Analysis of Antigen Conformational Flexibility and Peptide-MHCII Binding Affinity.

Tysheena Charles, Daniel L Moss, Pawan Bhat

|May 06, 2021
The Serpin-like Loop Insertion of Ovalbumin Increases the Stability and Decreases the OVA 323-339 Epitope Processing Efficiency.

Daniel L Moss, Ramgopal R Mettu, Samuel J Landry

Pageof 2

Frequent Collaborators

4 joint publications

Samuel J Landry

2 joint publications

Peter W Krug

2 joint publications

Masaru Kanekiyo

2 joint publications

Tracy J Ruckwardt